logo
logo

Immunomic Therapeutics, Inc. announced it raised $10 Million in an initial filing from an offering of $60 Million

Feb 26, 2020•over 5 years ago

Amount Raised

$10 Million

RockvilleBiotechnology

Company Information

Company

Immunomic Therapeutics

Location

ATTN: Erin Duffy, 15010 BROSCHART RD.

Rockville, Maryland, United States

About

Immunomic Therapeutics, Inc. (ITI) is a privately-held clinical stage biotechnology company pioneering the study of the Universal Intracellular Targeted Expression (UNITE) nucleic acid immunotherapy platform. This investigational technology has the potential to alter how we use immunotherapy for a number of diseases, including cancer, allergy and infectious diseases.

FundzWatch™ Score

69
Medium Activity

Buyer Intent Analysis

Get personalized insights on buying likelihood

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Related People